H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 11.64 +0.02 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.62 | 52 Week High | $34.49 | |||
| Open | $11.57 | 52 Week Low | $20.39 | |||
| Day High | $11.68 | P/E | N/A | |||
| Day Low | $10.97 | EPS | $-3.18 | |||
| Volume | 228,232 | |||||
